Memphasys (ASX:MEM)
ASX announcement history & article coverage
Transparent by design.
Announcments by Memphasys (ASX:MEM) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Memphasys Enters into Consulting Agreement with Director
Exclusive Thailand Commercialisation Agreement Secured
Memphasys secures exclusive three-year Felix™ distribution deal in Thailand worth A$430K
Section 708A Cleansing Statement
Application for quotation of securities - MEM
UK Market Entry & Acceleration of Commercial Expansion
Memphasys accelerates UK market entry with Felix™ System trials and initial orders
Investor Presentation - June 2026
Memphasys Investor Webinar
Proposed issue of securities - MEM
Successful $1.2M Placement and Convertible Note Extended
Memphasys Raises $1.2M to Support Felix™ Commercial Expansion and Extends Convertible Note
Trading Halt
Pause in Trading
Memphasys Limited trading halt announced
Memphasys Executes Supply Agreement with Monash IVF Group
Memphasys signs exclusive 12-month supply deal with Monash IVF for Felix™ system
South-East Asian Commercialization Agreement Secured
Memphasys Signs $530,000 Exclusive Felix™ Commercialisation Deal in Vietnam
ITL Orders 1000 Felix Cartridges Across MENA Markets
Memphasys Secures 1,000 Felix™ Cartridge Order from ITL, Expands MENA Market Reach
Initial Director's Interest Notice
Final Director's Interest Notice
Change of Chair
Updated Securities Trading Policy
Quarterly Activities/Appendix 4C Cash Flow Report
Memphasys achieves record quarterly revenue, secures multi-year contracts, and advances global commercialisation of Felix™ System
